Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BL.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BL.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.9.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.6.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CE.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DH.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XGNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JE.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JD.1.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCKNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GN.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GY.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HH.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDCNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.15.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JR.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JG.3.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KE.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.86.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDD.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HW.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GE.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCHNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JF.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used